User profiles for F. Barkhof
Frederik BarkhofVU University Medical Center Verified email at vumc.nl Cited by 168633 |
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
AJ Thompson, BL Banwell, F Barkhof… - The Lancet …, 2018 - thelancet.com
The 2010 McDonald criteria for the diagnosis of multiple sclerosis are widely used in research
and clinical practice. Scientific advances in the past 7 years suggest that they might no …
and clinical practice. Scientific advances in the past 7 years suggest that they might no …
Defining the clinical course of multiple sclerosis: the 2013 revisions
…, JS Wolinsky, LJ Balcer, B Banwell, F Barkhof… - Neurology, 2014 - AAN Enterprises
… F. Barkhof serves as a consultant for Bayer-Schering Pharma, Sanofi-Aventis, Biogen Idec,
Teva, Merck Serono, Novartis, Roche, Synthon, and Jansen Research. B. Bebo reports no …
Teva, Merck Serono, Novartis, Roche, Synthon, and Jansen Research. B. Bebo reports no …
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.
We compared MRI criteria used to predict conversion of suspected multiple sclerosis to
clinically definite multiple sclerosis. Seventy-four patients with clinically isolated neurological …
clinically definite multiple sclerosis. Seventy-four patients with clinically isolated neurological …
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
Cerebral small vessel disease (SVD) is a common accompaniment of ageing. Features
seen on neuroimaging include recent small subcortical infarcts, lacunes, white matter …
seen on neuroimaging include recent small subcortical infarcts, lacunes, white matter …
Consistent resting-state networks across healthy subjects
…, SARB Rombouts, F Barkhof… - Proceedings of the …, 2006 - National Acad Sciences
Functional MRI (fMRI) can be applied to study the functional connectivity of the human brain.
It has been suggested that fluctuations in the blood oxygenation level-dependent (BOLD) …
It has been suggested that fluctuations in the blood oxygenation level-dependent (BOLD) …
Atrophy of medial temporal lobes on MRI in" probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.
Magnetic resonance imaging (MRI) has shown a great reduction in medial temporal lobe
and hippocampal volume of patients with Alzheimer's disease as compared to controls. …
and hippocampal volume of patients with Alzheimer's disease as compared to controls. …
A new rating scale for age-related white matter changes applicable to MRI and CT
LO Wahlund, F Barkhof, F Fazekas, L Bronge… - Stroke, 2001 - Am Heart Assoc
Background and Purpose—MRI is more sensitive than CT for detection of age-related white
matter changes (ARWMC). Most rating scales estimate the degree and distribution of …
matter changes (ARWMC). Most rating scales estimate the degree and distribution of …
Reduced resting-state brain activity in the “default network” in normal aging
Normal aging is associated with cognitive decline. Functions such as attention, information
processing, and working memory are compromised. It has been hypothesized that not only …
processing, and working memory are compromised. It has been hypothesized that not only …
[HTML][HTML] Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis
Background Fingolimod (FTY720), a sphingosine-1-phosphate–receptor modulator that
prevents lymphocyte egress from lymph nodes, showed clinical efficacy and improvement on …
prevents lymphocyte egress from lymph nodes, showed clinical efficacy and improvement on …
[HTML][HTML] Two randomized phase 3 studies of aducanumab in early Alzheimer's disease
S Budd Haeberlein, PS Aisen, F Barkhof… - The journal of …, 2022 - Springer
Background Alzheimer’s disease is a progressive, irreversible, and fatal disease for which
accumulation of amyloid beta is thought to play a key role in pathogenesis. Aducanumab is a …
accumulation of amyloid beta is thought to play a key role in pathogenesis. Aducanumab is a …